Ion Beam Applications SA (OTCMKTS:IOBCF) Short Interest Update

Ion Beam Applications SA (OTCMKTS:IOBCF) saw a significant increase in short interest during the month of March. As of March 31st, there was short interest totaling 2,288 shares, an increase of 74.0% from the March 15th total of 1,315 shares. Based on an average daily trading volume, of 764 shares, the short-interest ratio is currently 3.0 days.

Ion Beam Applications Price Performance

Ion Beam Applications stock remained flat at $15.80 during midday trading on Monday. The firm has a 50 day moving average of $17.07 and a 200-day moving average of $15.37. Ion Beam Applications has a 12 month low of $10.95 and a 12 month high of $19.00.

Ion Beam Applications Company Profile

Ion Beam Applications (OTCMKTS: IOBCF) is a Belgium-based medical technology company specializing in the development and deployment of particle therapy solutions for cancer treatment. Founded in 1986 and headquartered in Louvain-la-Neuve, the company is best known for its Proteus® line of proton therapy systems, which are designed to deliver precise, high-energy particle beams that target tumors while sparing healthy tissue. IBA oversees the full project lifecycle, from system design and manufacturing to installation, commissioning, and ongoing service support.

In addition to its flagship proton therapy business, IBA operates a diversified portfolio of technologies for medical and industrial applications.